21.01.2014 13:20:45
|
Forest Labs Q3 Profit Beats View; Lifts FY14 Forecast - Quick Facts
(RTTNews) - Drug maker Forest Laboratories, Inc. (FRX) reported Tuesday a profit in its third quarter, compared to a loss last year. Adjusted earnings topped analysts' estimates. The company also lifted its fiscal 2014 forecast for adjusted earnings, above analysts' estimates.
For the quarter, net income was $17.96 million or $0.07 per share, compared to a loss of $153.61 million or $0.58 per share a year ago.
The latest quarter results included $28.2 million charge related to Project Rejuvenate. Adjusted earnings, which excluded items, were $73.97 million or $0.27 per share, compared to loss of $57.14 million or $0.21 per share last year.
On average, 19 analysts polled by Thomson Reuters expected earnings of $0.04 per share. Analysts' estimates typically exclude special items.
Net sales for the quarter increased 24.9 percent to $846.8 million from $678.0 million in the prior year, driven by sales of next generation products which increased 59.4 percent. Analysts expected sales of $827.25 million.
For the fiscal year ending March 31, 2014, the company now expects adjusted earnings per share to be in the range of $1.25 to $1.35, higher than previous forecast of $0.95 to $1.15 per share. Analysts project annual earnings of $1.10 per share.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Forest Laboratories Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |